An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Affiliated Chaohu Hospital of Anhui Medical Hospital, Chaohu, Anhui, China
Binhu Hospital of Hefei, Hefei, Anhui, China
The first Hospital of Hefei, Hefei, Anhui, China
University of Navarra Clinic, Pamplona, Navarra, Spain
CHU Clermont-Ferrand, Clermont-Ferrand, France
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Children's of Mississippi/University of Mississipi Medical Center, Jackson, Mississippi, United States
Seoul National University Hospital, Seoul, Agree, Korea, Republic of
Xijing Hospital, Xi'an, Shaanxi, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.